These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25349228)

  • 1. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke.
    Levin LÅ; Husberg M; Sobocinski PD; Kull VF; Friberg L; Rosenqvist M; Davidson T
    Europace; 2015 Feb; 17(2):207-14. PubMed ID: 25349228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
    Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
    Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording.
    Aronsson M; Svennberg E; Rosenqvist M; Engdahl J; Al-Khalili F; Friberg L; Frykman-Kull V; Levin LÅ
    Europace; 2015 Jul; 17(7):1023-9. PubMed ID: 25868469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan.
    Maeda K; Shimbo T; Fukui T
    J Med Screen; 2004; 11(2):97-102. PubMed ID: 15153326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke.
    Yong JH; Thavorn K; Hoch JS; Mamdani M; Thorpe KE; Dorian P; Sharma M; Laupacis A; Gladstone DJ;
    Stroke; 2016 Sep; 47(9):2380-5. PubMed ID: 27470989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved screening for silent atrial fibrillation after ischaemic stroke.
    Doliwa Sobocinski P; Anggårdh Rooth E; Frykman Kull V; von Arbin M; Wallén H; Rosenqvist M
    Europace; 2012 Aug; 14(8):1112-6. PubMed ID: 22308086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme.
    Proietti M; Farcomeni A; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY; Mairesse GH;
    Eur J Prev Cardiol; 2019 Jun; 26(9):964-972. PubMed ID: 30935219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
    Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
    Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J; Delaitre O; Hammès F; de Pouvourville G
    Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia.
    Mayer F; Stahrenberg R; Gröschel K; Mostardt S; Biermann J; Edelmann F; Liman J; Wasem J; Goehler A; Wachter R; Neumann A
    Clin Res Cardiol; 2013 Dec; 102(12):875-84. PubMed ID: 23904073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective.
    Maervoet J; Bossers N; Borge RP; Hilpert ST; van Engen A; Smala A
    J Med Econ; 2019 Nov; 22(11):1221-1234. PubMed ID: 31480905
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden.
    Davidson T; Husberg M; Janzon M; Oldgren J; Levin LÅ
    Eur Heart J; 2013 Jan; 34(3):177-83. PubMed ID: 22733833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Atrial Fibrillation with Intermittent Handheld Electrocardiogram in Patients with Ischemic Stroke and Transient Ischemic Attack.
    Olsson AS; Engdahl J
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2648-2652. PubMed ID: 27492946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland.
    Moran PS; Teljeur C; Harrington P; Smith SM; Smyth B; Harbison J; Normand C; Ryan M
    Value Health; 2016 Dec; 19(8):985-995. PubMed ID: 27987649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke.
    Kamel H; Hegde M; Johnson DR; Gage BF; Johnston SC
    Stroke; 2010 Jul; 41(7):1514-20. PubMed ID: 20508188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin.
    Lee S; Anglade MW; Meng J; Hagstrom K; Kluger J; Coleman CI
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):472-9. PubMed ID: 22740012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review.
    Chew DS; Rennert-May E; Spackman E; Mark DB; Exner DV
    Stroke; 2020 Jul; 51(7):2244-2248. PubMed ID: 32498661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
    Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW
    Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.